InVivoMAb anti-human CD19

Clone Catalog # Category
4G7 BE0281 InVivoMab Antibodies
$95 - $3250
SDS Sheet

About InVivoMAb anti-human CD19

The 4G7 monoclonal antibody reacts with human CD19, a B cell-specific 95 kDa transmembrane glycoprotein of the immunoglobulin superfamily. CD19 contains two extracellular immunoglobulin-like domains and an extensive cytoplasmic tail. It functions as a positive regulator of B-cell receptor signaling in conjunction with CD21 and CD81. CD19 is highly expressed in most lymphomas and leukemias including some early B-cell malignancies that do not express CD20. For these reasons CD19 is quickly becoming an attractive alternative target for the immunotherapy of lymphoproliferative disorders.

InVivoMAb anti-human CD19 Specifications


Mouse IgG1

Recommended Isotype Control(s) InVivoMAb mouse IgG1 isotype control, unknown specificity(BE0083)
Recommended InVivoPure Dilution Buffer InVivoPure pH 7.0 Dilution Buffer(IP0070)

Human chronic lymphocytic leukemia (CLL) cells

Reported Applications
  • Flow cytometry
  • Functional assays
  • Immunofluorescence
  • Chimeric antigen receptor construction (see Poirot, L., et al. reference)
  • <2EU/mg (<0.002EU/μg)
  • Determined by LAL gel clotting assay
  • >95%
  • Determined by SDS-PAGE
  • PBS, pH 7.0
  • Contains no stabilizers or preservatives

0.2 μM filtered


Purified from tissue culture supernatant in an animal free facility


Protein G


The antibody solution should be stored undiluted at 4°C, and protected from prolonged exposure to light. Do not freeze.



Molecular Weight

150 kDa

References provided by Bioz:

Disclaimer: These articles are provided by Bioz, an automated third-party article search engine. Given Bioz’s automation, these articles may not reflect the reported applications listed for this product. For an extensive up-to-date article list directly tailored to the reported applications listed for this product please see the Bio X Cell Application References by clicking the green button above.

Powered by Bioz

We're Heading to AACR

Come visit us at Booth 1842! See you in Atlanta!